GeneSoft®Human Epidermal Growth Factor(ARI Extended Type) Eye Drops
A Class 1 genetically engineered drug developed by Uni-Bio Science Group, with over 20 years of documented clinical application, indicated for treating corneal injuries of various etiologies and dry eye disease.
Corneal epithelial defects of various etiologies, including corneal mechanical trauma, postoperative states of corneal procedures, mild dry eye disease accompanied by superficial punctate keratopathy, and mild chemical burns.
15,000 IU/3 mL per vial
Product Features
Specifically binds to corneal epithelial and endothelial cell receptors, accelerating wound healing.
Enhances substance transport across cellular and subcellular membranes, promoting macromolecule synthesis, cell migration, and proliferation to support tissue repair.
Supplements tear film components and preserves lacrimal gland function.
Lubricates the ocular surface, inhibits scarring and angiogenesis, and enhances corneal transparency.
Product Advantages
-
Demonstrates superior efficacy to artificial tears by accelerating corneal healing and improving healing quality. -
Alleviates early post-laser responses, reduces bandage contact lens wear duration, and exhibits a favorable safety profile with no associated side effects.
More Products
-
Bogutai®Teriparatide InjectionBogutai® is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture.
-
GeneTime®Human Epidermal Growth Factor Derivative for External Use, LiquidGeneTime® is indicated for burn wounds (including superficial and deep second-degree burns), residual small wounds, various chronic ulcers (including vascular, radiation-induced, and diabetic ulcers), and fresh skin graft donor sites.
-
GeneSoft®Human Epidermal Growth Factor(ARI Extended Type) Eye DropsCorneal epithelial defects of various etiologies, including corneal mechanical trauma, postoperative states of corneal procedures, mild dry eye disease accompanied by superficial punctate keratopathy, and mild chemical burns.
